Sandoz Plugs Gap In Pipeline With $152m EirGenix Pertuzumab Alliance

Builds On Existing Relationship By Adding Biosimilar Rival To Perjeta

 
• By Dave Wallace
  
Sandoz has filled a hole in its biosimilars pipeline (Shutterstock)

More from Deals

More from Business